GLENMARK PHARMACEUTICALS Stock/ INE935A01035 /
2024-04-26 12:00:02 PM | Chg. -0.95 | Volume | Bid2024-04-26 | Ask12:32:43 PM | High | Low |
---|---|---|---|---|---|---|
1,079.35INR | -0.09% | 475,440 Turnover: 511.45 mill. |
1,081.00Bid Size: 28 | 1,079.35Ask Size: 7 | 1,088.75 | 1,061.25 |
GlobeNewswire
4:20 PM
MONDAY DEADLINE: Berger Montague Advises Nextdoor Holdings (NYSE: KIND) Investors to Inquire About a...
GlobeNewswire
4:15 PM
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lincoln Nation...
GlobeNewswire
4:09 PM
Globe Life Under Fire: DOJ Probe and Short-Seller Cast Shadow on Insurer - Hagens Berman
GlobeNewswire
4:01 PM
Autodesk, Inc. (ADSK) Faces Class Action Lawsuit for Potential Misrepresentation of Financials – Hag...
GlobeNewswire
4:00 PM
Protocase Hosts Federal Opposition Leader Pierre Poilievre on Site Tour and Meet-and-Greet
GlobeNewswire
4:00 PM
BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors w...
GlobeNewswire
3:51 PM
Breaking News: Is U.S. Silica's $15.50 Per Share Sale Price a Fair Deal? Johnson Fistel, LLP Investi...
GlobeNewswire
3:33 PM
NCLA Lawsuit Seeks to Set Aside the Department of Labor’s Unlawful New Independent Contractor Rule
GlobeNewswire
3:29 PM
Doximity, Inc. (DOCS) Investors: June 17, 2024 Filing Deadline in Securities Class Action - Contact ...
GlobeNewswire
3:25 PM
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that The Children’s Place, Inc....